Guangzhou RiboBio Co., Ltd. (RiboBio), founded in 2004, is a leading nucleic acids-based biotech company in China with over 240 employees and 6,500 sq meter space accommodating the cutting-edge facilities. The company develops and supplies a various DNA/RNA oligo, mRNA, RNAi, miRNA and lncRNA products. RiboBio established an oligonucleotide manufacturing facility supporting small to middle scale, low to high throughput, and oligo process development. RiboBio has a comprehensive oligonucleotide analytical lab accommodating with UPLC, HPLC, GC, IC, HTP-LC-MS, LC-qTOF-MS, LC-MS/MS, ICP-MS, GC-MS. In 2013, RiboBio built the first GMP oligonucleotide manufacturing facility in China and was issued the Oligo API Drug Manufacturing Permit by CFDA in June, 2016. Currently, our GMP facility has two synthesis rooms with one ÄKTA OligoPilot 100 (OP100), two ÄKTA OligoPilot 400 (OP400) synthesizers; three purification rooms with two ÄKTApurifier 100, one ÄKTA Pilot, and one ÄKTA Bioprocess. Our lyophilizer is capable of ~1000 grams of oligos for one batch lyophilization. Also, we are building a large scale GMP manufacturing facility for multiple kg scale (Oligoprocess max. 1800 mmol scale synthesizer) production, to be completed by the end of 2019.